The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy

[1] Aletaha D(2018)Diagnosis and management of rheumatoid arthritis: a review JAMA. 320 1360-1372

[2] Smolen JS(2019)Genetics of rheumatoid arthritis: 2018 status Ann Rheum Dis 78 446-453

[3] Okada Y(2017)Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis Ann Rheum Dis 76 1102-1107

[4] Eyre S(2016)2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis Arthritis Rheumatol 68 1-26

[5] Suzuki A(2020)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Ann Rheum Dis 79 685-699

[6] Kochi Y(2017)The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives Autoimmun Rev 16 1185-1195

[7] Yamamoto K(2010)Everything you wanted to know about Markov state models but were afraid to ask Methods. 52 99-105

[8] Chatzidionysiou K(2018)The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care Nat Med 24 1716-1720

[9] Emamikia S(2019)Development and validation of the Real-World Progression in Diabetes (RAPIDS) model Med Decis Mak 39 137-151

[10] Nam J(2007)Crossing the evidence chasm: building evidence bridges from process changes to clinical outcomes J Am Med Inform Assoc 14 329-339

[1] Aletaha D(2018)Diagnosis and management of rheumatoid arthritis: a review JAMA. 320 1360-1372

[2] Smolen JS(2019)Genetics of rheumatoid arthritis: 2018 status Ann Rheum Dis 78 446-453

[3] Okada Y(2017)Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis Ann Rheum Dis 76 1102-1107

[4] Eyre S(2016)2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis Arthritis Rheumatol 68 1-26

[5] Suzuki A(2020)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Ann Rheum Dis 79 685-699

[6] Kochi Y(2017)The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives Autoimmun Rev 16 1185-1195

[7] Yamamoto K(2010)Everything you wanted to know about Markov state models but were afraid to ask Methods. 52 99-105

[8] Chatzidionysiou K(2018)The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care Nat Med 24 1716-1720

[9] Emamikia S(2019)Development and validation of the Real-World Progression in Diabetes (RAPIDS) model Med Decis Mak 39 137-151

[10] Nam J(2007)Crossing the evidence chasm: building evidence bridges from process changes to clinical outcomes J Am Med Inform Assoc 14 329-339